JPMorgan prefers other assets that offer annual yields. UBS, meanwhile, says gold price growth is likely to slow.
Related Posts
Novo Nordisk shares pop 9% on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Here are the 5 things that could move the stock market in the week ahead
Earnings drove the stock market higher — can they do it again in the next week?
Sen. Chris Van Hollen meets with Kilmar Abrego Garcia in El Salvador
The Maryland Democrat flew to the Central American country this week to meet with Abrego Garcia, who the Trump administration says was mistakenly deported.